Immediate Surgery Compared with Short-Course Neoadjuvant Gemcitabine Plus Capecitabine, FOLFIRINOX, or Chemoradiotherapy in Patients with Borderline Resectable Pancreatic Cancer (ESPAC5): a Four-Arm, Multicentre, Randomised, Phase 2 Trial Paula Ghaneh , Daniel Palmer , Silvia Cicconi , Richard Jackson , Christopher Michael Halloran , Charlotte Rawcliffe , Rajaram Sripadam , Somnath Mukherjee , Zahir Soonawalla , Jonathan Wadsley , Ahmed Al-Mukhtar , Euan Dickson , Janet Graham , Long Jiao , Harpreet S. Wasan , Iain S. Tait , Andreas Prachalias , Paul Ross , Juan W. Valle , Derek A. O'Reilly , Bilal Al-Sarireh , Sarah Gwynne , Irfan Ahmed , Kate Connolly , Kein-Long Yim , David Cunningham , Thomas Armstrong , Caroline Archer , Keith Roberts , Yuk Ting Ma , Christoph Springfeld , Christine Tjaden , Thilo Hackert , Markus W. Buchler , John P. Neoptolemos LANCET GASTROENTEROLOGY & HEPATOLOGY（2023）
关键词
Neoadjuvant Therapy, Pancreatic Neuroendocrine Tumors, Peptide Receptor Radionuclide Therapy, Metastatic Pancreatic Cancer, Pancreatic Cancer
AI 理解论文
溯源树
样例
